Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Neurodevelopmental Disorders
|
December 29, 2017
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model
Heng Dai, Chad R Jackson, Gwynne L Davis, et al.
Behavioural Brain Research
|
October 2, 2017
Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice
Gwynne L Davis, Adele Stewart, Gregg D Stanwood, et al.
Nature Communications
|
October 16, 2021
Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice
Gwynne L Davis, Adelaide R Minerva, Argentina Lario, et al.
Journal of Psychiatric Research
|
June 6, 2022
Valence processing alterations in SAPAP3 knockout mice and human OCD
Bridget L Kajs, Peter J van Roessel, Gwynne L Davis, et al.
Cells
|
December 23, 2022
Male DAT Val559 Mice Exhibit Compulsive Behavior under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes
Adele Stewart, Gwynne L Davis, Lorena B Areal, et al.
Neurochemistry International
|
December 17, 2013
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder
Marc A Mergy, Raajaram Gowrishankar, Gwynne L Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 10, 2018
Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D<sub>2</sub> Autoreceptors Shapes the <i>In Vivo</i> Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559
Raajaram Gowrishankar, Paul J Gresch, Gwynne L Davis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 23, 2018
Serotonin transporter inhibition and 5-HT<sub>2C</sub> receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice
Adele Stewart, Gwynne L Davis, Paul J Gresch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 22, 2014
The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants
Marc A Mergy, Raajaram Gowrishankar, Paul J Gresch, et al.
Molecular Psychiatry
|
September 18, 2022
Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters
Adele Stewart, Felix P Mayer, Raajaram Gowrishankar, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Neurodevelopmental Disorders
|
December 29, 2017
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model
Heng Dai, Chad R Jackson, Gwynne L Davis, et al.
Behavioural Brain Research
|
October 2, 2017
Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice
Gwynne L Davis, Adele Stewart, Gregg D Stanwood, et al.
Nature Communications
|
October 16, 2021
Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice
Gwynne L Davis, Adelaide R Minerva, Argentina Lario, et al.
Journal of Psychiatric Research
|
June 6, 2022
Valence processing alterations in SAPAP3 knockout mice and human OCD
Bridget L Kajs, Peter J van Roessel, Gwynne L Davis, et al.
Cells
|
December 23, 2022
Male DAT Val559 Mice Exhibit Compulsive Behavior under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes
Adele Stewart, Gwynne L Davis, Lorena B Areal, et al.
Neurochemistry International
|
December 17, 2013
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder
Marc A Mergy, Raajaram Gowrishankar, Gwynne L Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 10, 2018
Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D<sub>2</sub> Autoreceptors Shapes the <i>In Vivo</i> Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559
Raajaram Gowrishankar, Paul J Gresch, Gwynne L Davis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 23, 2018
Serotonin transporter inhibition and 5-HT<sub>2C</sub> receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice
Adele Stewart, Gwynne L Davis, Paul J Gresch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 22, 2014
The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants
Marc A Mergy, Raajaram Gowrishankar, Paul J Gresch, et al.
Molecular Psychiatry
|
September 18, 2022
Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters
Adele Stewart, Felix P Mayer, Raajaram Gowrishankar, et al.
Page
of 1